Intuitive Surgical Down Over 5%, on Pace for Largest Percent Decrease Since August 2022 — Data Talk
Intuitive Surgical, Inc. (ISRG) is currently at $281.08, down $16.75 or 5.62%
--Would be lowest close since April 18, 2023, when it closed at $269.28
--On pace for largest percent decrease since Aug. 26, 2022, when it fell 6.19%
--Currently down three of the past five days
--Down 3.84% month-to-date
--Up 5.93% year-to-date; on pace for best year since 2021, when it rose 31.76%
--Down 23.08% from its all-time closing high of $365.42 on Nov. 8, 2021
--Up 50.84% from 52 weeks ago (Oct. 12, 2022), when it closed at $186.34
--Down 20.81% from its 52-week closing high of $354.93 on July 18, 2023
--Up 53.55% from its 52-week closing low of $183.06 on Oct. 14, 2022
--Traded as low as $280.32; lowest intraday level since April 18, 2023, when it hit $266.45
--Down 5.88% at today's intraday low; largest intraday percent decrease since Jan. 25, 2023, when it fell as much as 7.42%
--Fifth worst performer in the S&P 500 today
--Second worst performer in the Nasdaq 100 today
All data as of 10:22:37 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 11, 2023 10:39 ET (14:39 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
Should Emerging-Markets Stocks Stand Alone in Your Portfolio?
-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
3 Dividend Stocks for October 2024
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued